Evidence map›Paper›PMID 33668644›Full record

ArticleJournal of personalized medicine2021

18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis.

Tetiana Skrypets, Cristina Ferrari, Luca Nassi, Gloria Margiotta Casaluci, Benedetta Puccini, Lara Mannelli, Kateryna Filonenko, Irina Kryachok, Felice Clemente, Maria Carmela Vegliante and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Tetiana SkrypetsHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0002-2276-869X
Cristina FerrariD.I.M.-Diagnostic Imaging-Nuclear Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-0168-8551
Luca NassiHaematology Department, Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.
Gloria Margiotta CasaluciHaematology Department, Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.
Benedetta PucciniHematology Department, Azienda Ospedaliera Careggi, 50139 Firenze, Italy.
Lara MannelliHematology Department, Azienda Ospedaliera Careggi, 50139 Firenze, Italy.
Kateryna FilonenkoOncohematology Department, National Cancer Institute, 03022 Kyiv, Ukraine.
Irina KryachokOncohematology Department, National Cancer Institute, 03022 Kyiv, Ukraine.
Felice ClementeHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Maria Carmela VeglianteHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Antonella DanieleExperimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Gianmauro SacchettiNuclear Medicine, AOU Maggiore della Carità, 28100 Novara, Italy.
Attilio GuariniHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.
Carla MinoiaHaematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy.ORCID 0000-0002-5707-0689
Istituto Tumori Bari · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITAzienda Ospedaliero-Universitaria Careggi · ITNational Cancer Institute · UAUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of gastrointestinal (GI) involvement in Mantle Cell Lymphoma is often underestimated and may have an impact on outcome and clinical management. We aimed to evaluate whether baseline 18F-FDG PET/CT presents comparable results to endoscopic biopsy in the diagnosis of GI localizations. In our retrospective cohort of 79 patients, sensitivity and specificity of 18F-FDG PET/CT were low for the stomach, with a fair concordance (

Indexed as

18F-FDG PET/CTcolorectal biopsyendoscopygastric biopsyMantle Cell Lymphomastaging

Identifiers

PMID33668644
PMCPMC7918751
OpenAlexW3132341139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.